{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-24-000049","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.407792+00:00","generated_at":"2026-05-30T11:02:24.943548+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"iBio updates corporate presentation; no specific material changes disclosed","bullets":["iBio furnished an updated corporate presentation dated October 2024, focused on precision antibody therapeutics powered by machine learning.","No new financial guidance, pipeline milestones, or operational metrics were provided in the 8-K filing.","The presentation is furnished under Regulation FD and not incorporated by reference into SEC filings."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-24-000049","json":"https://secwatch.observer/filing/0001420720-24-000049.json","markdown":"https://secwatch.observer/filing/0001420720-24-000049.md","text":"https://secwatch.observer/filing/0001420720-24-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072024000049/0001420720-24-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072024000049/ibio-20241023x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:02:24.943548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}